PRCT Q1 2022 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+97.4% YoY

Gross Profit

$8M54.2% margin

Operating Income

-$16M-110.6% margin

Net Income

-$17M-121.0% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+40.0%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$321M

Total Liabilities

$68M

Stockholders' Equity

$253M

Cash & Equivalents

$284M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$7M	+97.4%
Gross Profit	$8M	$4M	+118.1%
Operating Income	-$16M	-$11M	-38.4%
Net Income	-$17M	-$13M	-34.0%

Geographic Segments

UNITED STATES

$8M91%

Outside the United States

$742,0009%